drugset / Trial / NCT01102387

Efficacy and Safety of LAS41003 in the Treatment of Intertriginous Candida Infections

NCT01102387

Phase 2 Completed 137 enrolled Almirall, S.A.
RandomizedParallel-groupQuadruple-blindTreatment

Summary

The aim of this study is to determine the efficacy and safety of once daily topical application of the combinational cream LAS41003 compared to the corresponding mono-substances in the treatment of candida infections in intertriginous areas at the trunk.

Timeline

Start
2010-02
Primary completion
2011-07
Completion
2011-07

Drugs

EvaluationDrugModalityDoseRoute
Subject LAS41003 Unknown Topical
Comparator Octenidine Small molecule Topical
Comparator Prednicarbate Small molecule Topical

Indications